[go: up one dir, main page]

IL132145A - Compositions for treating inflammatory bowel disease and uses thereof - Google Patents

Compositions for treating inflammatory bowel disease and uses thereof

Info

Publication number
IL132145A
IL132145A IL13214598A IL13214598A IL132145A IL 132145 A IL132145 A IL 132145A IL 13214598 A IL13214598 A IL 13214598A IL 13214598 A IL13214598 A IL 13214598A IL 132145 A IL132145 A IL 132145A
Authority
IL
Israel
Prior art keywords
compositions
inflammatory bowel
bowel disease
treating inflammatory
treating
Prior art date
Application number
IL13214598A
Other languages
English (en)
Other versions
IL132145A0 (en
Original Assignee
Borody Thomas J
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPO5940A external-priority patent/AUPO594097A0/en
Priority claimed from AUPO9785A external-priority patent/AUPO978597A0/en
Application filed by Borody Thomas J filed Critical Borody Thomas J
Publication of IL132145A0 publication Critical patent/IL132145A0/xx
Publication of IL132145A publication Critical patent/IL132145A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Mycology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL13214598A 1997-04-01 1998-04-01 Compositions for treating inflammatory bowel disease and uses thereof IL132145A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPO5940A AUPO594097A0 (en) 1997-04-01 1997-04-01 Novel methods of treating inflammatory bowel disease
AUPO9785A AUPO978597A0 (en) 1997-10-14 1997-10-14 Methods of treating inflammatory bowel disease
PCT/AU1998/000222 WO1998043667A1 (fr) 1997-04-01 1998-04-01 Composition et procede servant a traiter la maladie intestinale inflammatoire

Publications (2)

Publication Number Publication Date
IL132145A0 IL132145A0 (en) 2001-03-19
IL132145A true IL132145A (en) 2005-11-20

Family

ID=25645389

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13214598A IL132145A (en) 1997-04-01 1998-04-01 Compositions for treating inflammatory bowel disease and uses thereof

Country Status (16)

Country Link
US (1) US6277836B1 (fr)
EP (1) EP0971735B1 (fr)
JP (3) JP2001524951A (fr)
AR (1) AR012304A1 (fr)
AT (1) ATE389417T1 (fr)
CA (1) CA2285923C (fr)
CY (1) CY1109783T1 (fr)
DE (1) DE69839261T2 (fr)
DK (1) DK0971735T3 (fr)
ES (1) ES2303351T3 (fr)
IL (1) IL132145A (fr)
NO (1) NO325947B1 (fr)
NZ (1) NZ500696A (fr)
PT (1) PT971735E (fr)
SI (1) SI0971735T1 (fr)
WO (1) WO1998043667A1 (fr)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6551632B2 (en) * 1997-04-01 2003-04-22 Thomas Julius Borody Methods and compositions for treating inflammatory bowel disease
AUPP325398A0 (en) * 1998-04-30 1998-05-21 Borody, Thomas J. Improved method for eradicating h. pylori
JP2002536404A (ja) * 1999-02-12 2002-10-29 ワシントン ユニバーシティー 炎症性腸疾患を治療するための好中球機能の刺激
PE20010635A1 (es) * 1999-10-08 2001-08-15 Smithkline Beecham Corp Inhibidores de fab i utiles para el tratamiento de infecciones bacterianas
JP3369535B2 (ja) 1999-11-09 2003-01-20 松下電器産業株式会社 プラズマディスプレイ装置
US7638496B2 (en) 2000-02-15 2009-12-29 Valeant Pharmaceuticals North America Nucleoside analogs with carboxamidine modified monocyclic base
NZ521368A (en) * 2000-03-28 2004-05-28 Biochemie Ges M Granulated particles of an active compound, with a film-forming coating resulting in the masked taste of said active compound
AU2001285311B2 (en) 2000-08-29 2005-09-15 Biocon, Ltd Immunoregulatory compounds, derivatives thereof and their use
DK1560584T3 (da) * 2001-04-06 2009-05-18 Affinium Pharm Inc Fab I inhibitorer
US8048924B2 (en) 2001-08-29 2011-11-01 Biocon Limited Methods and compositions employing 4-aminophenylacetic acid compounds
US20030118329A1 (en) * 2001-12-21 2003-06-26 Pere Obrador Video indexing using high resolution still images
AUPS088702A0 (en) * 2002-03-04 2002-03-28 Borody, Thomas Julius Electrolyte purgative
DK1575951T3 (da) * 2002-12-06 2014-09-15 Debiopharm Int Sa Heterocykliske forbindelser, fremgangsmåder til fremstilling deraf og deres anvendelse i terapi
CA2519429C (fr) 2003-03-17 2013-08-06 Affinium Pharmaceuticals, Inc. Compositions pharmaceutiques comportant des inhibiteurs de fab i et autres antibiotiques
US6930093B2 (en) * 2003-07-10 2005-08-16 Valeant Research & Development Use of ribofuranose derivatives against inflammatory bowel diseases
WO2005046567A2 (fr) * 2003-09-10 2005-05-26 Meena Shelgaonkar Preparation synergique d'agents antioxydants et antimycobacteriens, procede de production de cette derniere
AU2004314731B2 (en) * 2004-01-20 2011-07-07 The Board Of Regents Of The University Of Oklahoma Compositions and methods of treatment for inflammatory diseases
NZ549661A (en) 2004-02-06 2010-07-30 Pharmatel R & D Pty Ltd As Tru Use of aminosalicylates in diarrhoea-predominant irritable bowel syndrome
JP5009152B2 (ja) * 2004-05-28 2012-08-22 サリックス ファーマシューティカルズ， インコーポレイテッド 放射線誘発性腸炎の予防、処置、および回復
KR101299399B1 (ko) 2004-06-04 2013-08-22 아피늄 파마슈티컬스, 인크. 치료제, 및 그의 제조 및 사용 방법
US7932366B2 (en) 2004-07-07 2011-04-26 Biocon Limited Synthesis of azo bonded immunoregulatory compounds
US8921344B2 (en) * 2006-11-03 2014-12-30 Salix Pharmaceuticals, Inc. Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
CN103948609A (zh) * 2005-08-24 2014-07-30 萨利克斯药品公司 巴柳氮制剂及其生产和应用
US7452872B2 (en) 2005-08-24 2008-11-18 Salix Pharmaceuticals, Inc. Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
US20090156578A1 (en) * 2005-12-05 2009-06-18 PAULS Henry 3-Heterocyclylacrylamide Compounds as Fab I Inhibitors and Antibacterial Agents
CA2531261A1 (fr) * 2005-12-21 2007-06-21 Institut Pasteur Traitement de syndromes d'inflammation intestinale a l'aide d'une preparation a base de bacteries tuees ou non infectieuses
WO2008009122A1 (fr) 2006-07-20 2008-01-24 Affinium Pharmaceuticals, Inc. Dérivés d'acrylamide en tant qu'inhibiteurs de fab i
EP2125802A4 (fr) * 2007-02-16 2014-08-20 Debiopharm Int Sa Sels, promédicaments et polymorphes d'inhibiteurs de fab 1
US8436051B2 (en) 2007-06-08 2013-05-07 Aptalis Pharma Canada Inc. Mesalamine suppository
US7541384B2 (en) 2007-06-08 2009-06-02 Axcan Pharma Inc. Mesalamine suppository
US8217083B2 (en) * 2007-06-08 2012-07-10 Aptalis Pharma Canada Inc. Mesalamine suppository
US20090098088A1 (en) * 2007-10-10 2009-04-16 The Procter & Gamble Company Methods And Kits For The Treatment Of Diverticular Conditions
WO2009047801A1 (fr) * 2007-10-10 2009-04-16 Lupin Limited Combinaisons thérapeutiques et compositions pour le traitement de troubles gastro-intestinaux
WO2009064953A1 (fr) * 2007-11-15 2009-05-22 Enanta Pharmaceuticals, Inc. Utilisation de dérivés de tylosine ou de macrolides pontés pour le traitement d'affections intestinales inflammatoires non spécifiques
TR201819940T4 (tr) * 2008-02-08 2019-01-21 Red Hill Biopharma Ltd Enflamatuar bağırsak hastalığının tedavisi için yöntemler ve bileşimler.
MX2010011995A (es) * 2008-05-01 2010-12-02 Procter & Gamble Metodos y estuches para el tratamiento de condiciones y trastornos inflamatorios del intestino.
US20110082120A1 (en) * 2009-10-05 2011-04-07 Milne Jill C Substituted thioacetic acid salicylate derivatives and their uses
EP2493471B1 (fr) 2009-10-26 2019-11-27 Thomas Julius Borody Nouvelle polythérapie gastro-résistante
US8497256B2 (en) 2010-04-26 2013-07-30 Salix Pharmaceuticals, Ltd Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives for the treatment of males
MX355760B (es) 2010-12-13 2018-04-27 Salix Pharmaceuticals Inc Formulaciones gástricas y colónicas y métodos para elaborar y usar las mismas.
TWI573590B (zh) * 2011-09-20 2017-03-11 雷希爾生藥有限公司 治療自體免疫疾病之組成物及方法
BR122021020778B1 (pt) 2012-06-19 2022-07-12 Debiopharm International Sa Derivados de pró-fármaco de (e)-n-metil-n-((3-metilbenzofuran-2-il) metil)-3-(7-oxo-5,6,7,8-tetraidro- 1, 8- naftirindin-3-il) acrilamida
JP6454640B2 (ja) 2012-07-27 2019-01-16 レッド ヒル バイオファーマ リミテッドＲｅｄＨｉｌｌ Ｂｉｏｐｈａｒｍａ Ｌｔｄ． 結腸排出促進における使用のための製剤および製剤製造方法
CN110693905A (zh) * 2014-05-22 2020-01-17 约翰·托德·金斯特纳 使用紫外线血液辐照和抗生素的组合治疗疾病
SI3419628T1 (sl) 2016-02-26 2021-03-31 Debiopharm International Sa Zdravilo za zdravljenje infekcij diabetičnega stopala
PH12021551922A1 (en) 2019-02-14 2022-05-23 Debiopharm Int Sa Afabicin formulation, method for making the same
UA129222C2 (uk) 2019-06-14 2025-02-12 Дебіофарм Інтернешнл С.А. Лікарський засіб і його застосування для лікування бактеріальних інфекцій, пов'язаних з біоплівкою
AU2021298936A1 (en) 2020-06-30 2023-01-19 Redhill Biopharma Ltd. Triple antibiotic fixed-dose combination products, dosing regimen, methods, and kits for treating pulmonary non-tuberculosis mycobacterial infections
WO2025026423A1 (fr) * 2023-08-02 2025-02-06 Shenzhen Pharmacin Co., Ltd. Compositions, leur utilisation et leur fabrication pour le traitement d'affections gastro-intestinales

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4440763A (en) * 1981-03-18 1984-04-03 Block Drug Company, Inc. Use of 4-aminosalicyclic acid as an anti-inflammatory agent
GB8919321D0 (en) * 1989-08-25 1989-10-11 Univ London Treatment of chronic inflammatory conditions

Also Published As

Publication number Publication date
NO994778L (no) 1999-11-30
JP2008024713A (ja) 2008-02-07
DE69839261T2 (de) 2009-03-26
PT971735E (pt) 2008-06-02
EP0971735A4 (fr) 2004-02-25
CA2285923A1 (fr) 1998-10-08
AR012304A1 (es) 2000-10-18
EP0971735A1 (fr) 2000-01-19
DK0971735T3 (da) 2008-07-07
CA2285923C (fr) 2013-03-12
NO994778D0 (no) 1999-09-30
ATE389417T1 (de) 2008-04-15
JP2012126736A (ja) 2012-07-05
NO325947B1 (no) 2008-08-25
CY1109783T1 (el) 2013-09-04
ES2303351T3 (es) 2008-08-01
JP2001524951A (ja) 2001-12-04
EP0971735B1 (fr) 2008-03-19
IL132145A0 (en) 2001-03-19
DE69839261D1 (de) 2008-04-30
SI0971735T1 (sl) 2008-08-31
US6277836B1 (en) 2001-08-21
WO1998043667A1 (fr) 1998-10-08
NZ500696A (en) 2002-05-31

Similar Documents

Publication Publication Date Title
IL132145A (en) Compositions for treating inflammatory bowel disease and uses thereof
PL336580A1 (en) Fine-molecular compounds useful in treating inflammatory diseases
ZA98454B (en) Personal cleansing compositions
PL336840A1 (en) Hair-care composition
EP0766564A4 (fr) Compositions a base de polypeptides et a liberation lente, et procedes de traitement des affections intestinales inflammatoires
BG105437A (en) REFLECTIVELY MODIFIED COMPOSITIONS AND METHODS FOR OBTAINING THEM
EP1020194A4 (fr) Compositions d'emulsions de type aqueux
GB9819530D0 (en) Novel compositions and use
ZA98455B (en) Personal cleansing compositions
EP1056456A4 (fr) Compositions et procedes d'utilisation du r-lansoprazole
GB9720797D0 (en) Pharmaceutical composition for the treatment of inflammatory bowel disease and irritable bowel syndrome
AU6386499A (en) Method and composition for treatment of inflammatory bowel disease
GB9607963D0 (en) Cleansing composition
HUP0000460A3 (en) Imidazopyridazines and pharmaceutical compositions thereof
GB9806537D0 (en) Polyester compositions
GB9901577D0 (en) Polyester compositions
PL330353A1 (en) Detergent hair-care compositions and their application
IL120488A0 (en) Modifiers for water-setting inorganic compositions and modified water-setting inorganic compositions
HUP0400922A3 (en) Detergent compositions and their use
GB9824450D0 (en) Malodour counteractant compositions
ZA982645B (en) Methods and compositions for treating inflammatory bowel disease
PL342253A1 (en) Pharmacological compositions based on bibapticide for visualising and treating thrombuses
PL338379A1 (en) Novel photoinitiators and their application
GB9725346D0 (en) Pharmaceutical composition for the treatment of inflammatory bowel disease
GB9701041D0 (en) Treatment of inflammatory bowel conditions

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired